title: Surgical treatment of periodontal intrabony defects with calcium sulphate in combination with beta tricalcium phosphate--a 12-month retrospective clinical evaluation.
abstract: Alloplastic bone graft materials are widely been used in combination with barrier membranes to achieve guided tissue regeneration in the treatment of periodontal intrabony defects. This study was designed to evaluate the clinical outcome of a composite material, beta tricalcium phosphate in combination with calcium sulphate in the treatment of periodontal intrabony defects. The combination of these materials is believed to aid in guided tissue regeneration owing to their properties. Thirty nine intrabony defects in 21 patients were treated with Fortoss Vital (Biocomposites, Staffordshire, UK). Clinical parameters were evaluated including changes in probing depth, clinical attachment level/loss and gingival recession at baseline and one year postoperatively. The mean differences in measurements between the baseline and one year postoperatively are a reduction of 1.98 +/- 1.16 mm (p = 0.000) in case of probing depth and a gain of 1.68 +/- 1.12 mm (p = 0.000) in clinical attachment level and an increase of 0.31 +/- 0.67 mm (p = 0.009) in gingival recession measurements. The study results show that the treatment with a combination of beta tricalcium phosphate and calcium sulphate led to a significantly favorable clinical improvement in periodontal intrabony defects one year postoperatively.
authors.affiliation: Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Králové, Czech Republic. docsujith@gmail.com
authors.forename: Sujith
authors.initials: S
authors.lastname: Sukumar
authors.forename: Ivo
authors.initials: I
authors.lastname: Drízhal
authors.forename: Josef
authors.initials: J
authors.lastname: Bukac
authors.forename: Vladimíra
authors.initials: V
authors.lastname: Paulusová
authors.forename: Shriharsha
authors.initials: S
authors.lastname: Pilathadka
mesh_terms: D016301:Alveolar Bone Loss / Q000628:therapy; D001672:Biocompatible Materials / Q000008:administration & dosage*; D018786:Bone Substitutes / Q000008:administration & dosage*; D002130:Calcium Phosphates / Q000008:administration & dosage*; D002133:Calcium Sulfate / Q000008:administration & dosage*; D003764:Dental Materials; D005260:Female; D016557:Guided Tissue Regeneration, Periodontal; D006801:Humans; D008297:Male; D008875:Middle Aged; D010510:Periodontal Diseases / Q000175:diagnosis / Q000628:therapy*; D055815:Young Adult
chemical_list: D001672:Biocompatible Materials; D018786:Bone Substitutes; D002130:Calcium Phosphates; D003764:Dental Materials; C485817:beta-tricalcium phosphate; D002133:Calcium Sulfate